Posts in category
Therapeutic Update
Biosimilars—here to stay (Updated July 2021)
Up until now, most biosimilars have been in the domain of public and private hospitals, however the release shortly of biosimilar adalimumab, which is currently a self-administered subcutaneous injection, means …
Pre-eclampsia and the use of aspirin in its prevention
Inconsistent messaging and advice from healthcare providers has been found to negatively impact women’s adherence with aspirin in pregnancy. All healthcare providers, including pharmacists, play an important role in accurately …